The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
KEYNOTE-164: Phase 2 study of pembrolizumab for patients with previously treated, microsatellite instability-high advanced colorectal carcinoma.
 
Dung T. Le
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Merck
 
Thierry Andre
Honoraria - Amgen; Baxter; BAYER; Bristol-Myers Squibb; Lilly; Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Roche/Genentech
 
Tae Won Kim
Honoraria - Amgen; Lilly
Research Funding - Bayer; EMD Serono; Merck; Roche/Genentech
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Dirk Jäger
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche/Genentech
 
Ravit Geva
No Relationships to Disclose
 
Hiroki Hara
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Tae-You Kim
No Relationships to Disclose
 
Takayuki Yoshino
Research Funding - Sumitomo Dainippon
 
Matthew E. Burge
Stock and Other Ownership Interests - CSL Behring; ResMed; Sertex
Honoraria - Novartis; Roche
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Hiroya Taniguchi
Honoraria - Chugai Pharma; EMD Serono; Merck; Otsuka; Taiho Pharmaceutical; Takeda
 
Elena Elez
No Relationships to Disclose
 
Chloe Evelyn Atreya
Consulting or Advisory Role - Bayer
Research Funding - GlaxoSmithKline; Merck; Novartis
 
Johanna C. Bendell
No Relationships to Disclose
 
Minori Koshiji
Employment - Merck
 
Ruixue Wang
Employment - Merck
 
S. Peter Kang
No Relationships to Disclose
 
Luis A. Diaz
Employment - Personal Genome Diagnostics
Leadership - Personal Genome Diagnostics
Stock and Other Ownership Interests - Personal Genome Diagnostics
Travel, Accommodations, Expenses - Merck